{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T03:56:09Z","timestamp":1788062169224,"version":"build-2784847793"},"reference-count":32,"publisher":"IMR Press","issue":"1","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"2023 Chizhou City major science and technology special project"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background: Gastric cancer (GC) remains a major global health burden, particularly in East Asia, with complex etiologies involving Helicobacter pylori infection, diet, host genetics, and environmental exposures. GC development follows the Correa sequence (CS), a multistep cascade from gastritis to atrophy, erosion, and carcinoma. Although gut microbiota (GM) dysbiosis and metabolic reprogramming have each been implicated in GC, their integrated dynamics across CS remain incompletely defined. Methods: We recruited participants across five groups: normal controls (G1), gastritis (G2), atrophy (G3), erosion (G4), and GC (G5). Fecal and gastric tissue samples were analyzed using 16S rRNA sequencing and untargeted metabolomics under both ion modes. Microbial diversity was assessed by \u03b1- and \u03b2-diversity indices, linear discriminant analysis effect size (LEfSe), and functional prediction. Metabolic features were profiled by UHPLC-Q Exactive Orbitrap MS, and differential metabolites were identified using t-tests and partial least squares discriminant analysis (PLS-DA). Diagnostic potential was evaluated using receiver operating characteristic (ROC) curves. Results: Microbial \u03b1-diversity decreased significantly with progression, particularly in G3, while compositional shifts included depletion of Bacteroides and Faecalibacterium alongside enrichment of Actinobacteria, Peptostreptococcaceae, and Lachnoclostridium. LEfSe identified Bifidobacterium and Oscillospiraceae as potential biomarkers of advanced stages. ROC analyses demonstrated strong discriminatory power, with the class Actinobacteria achieving an area under the ROC curve (AUC) of 0.935 in distinguishing controls from GC. Fecal metabolomics revealed reductions in anti-inflammatory short-chain fatty acids (SCFAs) and increases in pro-inflammatory metabolites emerging at G3, while tissue metabolomics showed broader reprogramming in GC involving amino acid, nucleotide, lipid, and energy metabolism. Notably, erosion (G4) exhibited transitional features, whereas atrophy (G3) marked a distinct metabolic \u201cbreakpoint\u201d. Conclusions: By integrating GM and metabolomic data, this study delineates stage-specific microbial and metabolic alterations along the CS. Atrophy represents a pivotal inflection point in the transition from homeostasis to carcinogenesis, while erosion serves as a transitional state. Combined microbiota\u2013metabolite signatures hold promise for non-invasive early detection, disease stratification, and mechanistic insights into metabolic dependencies in GC.<\/jats:p>","DOI":"10.31083\/fbl46553","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:05:26Z","timestamp":1769688326000},"source":"Crossref","is-referenced-by-count":1,"title":["Gut Microbiota and Metabolome Dynamics Along Gastric Cancer Progression: An Exploratory Multi-Omics Analysis"],"prefix":"10.31083","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5717-9232","authenticated-orcid":true,"given":"Jingfang","family":"Yang","sequence":"first","affiliation":[{"name":"Gastroenterology Department, The People\u2019s Hospital of Chizhou, 247100 Chizhou, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2132-5014","authenticated-orcid":true,"given":"Binbin","family":"Wang","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, The People\u2019s Hospital of Chizhou, 247100 Chizhou, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7216-3326","authenticated-orcid":true,"given":"Yanfei","family":"Yu","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, The People\u2019s Hospital of Chizhou, 247100 Chizhou, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9581-5065","authenticated-orcid":true,"given":"Hansheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, The People\u2019s Hospital of Chizhou, 247100 Chizhou, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4267-9640","authenticated-orcid":true,"given":"Xueyong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, The People\u2019s Hospital of Chizhou, 247100 Chizhou, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1212-0060","authenticated-orcid":true,"given":"Guangwen","family":"Wu","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, The People\u2019s Hospital of Chizhou, 247100 Chizhou, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2649-2552","authenticated-orcid":true,"given":"Yan","family":"Liu","sequence":"additional","affiliation":[{"name":"Research and Development Center, Center of Human Microecology Engineering and Technology of Guangdong Province, 510700 Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2181-5944","authenticated-orcid":true,"given":"Xiangyang","family":"Shi","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, The People\u2019s Hospital of Chizhou, 247100 Chizhou, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Mithany RH, Shahid MH, Manasseh M, Saeed MT, Aslam S, Mohamed MS, et al. Gastric Cancer: A Comprehensive Literature Review. Cureus. 2024; 16: e55902.","DOI":"10.7759\/cureus.55902"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Yang WJ, Zhao HP, Yu Y, Wang JH, Guo L, Liu JY, et al. Updates on global epidemiology, risk and prognostic factors of gastric cancer. World Journal of Gastroenterology. 2023; 29: 2452\u20132468.","DOI":"10.3748\/wjg.v29.i16.2452"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Gao S, Wei G, Ma Q, Wang X, Wang S, Niu Y. Causal relationship between anti-inflammatory drugs and cancer: a pan-cancer study with Mendelian randomization. Frontiers in Genetics. 2024; 15: 1392745.","DOI":"10.3389\/fgene.2024.1392745"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Morais S, Costa A, Albuquerque G, Ara\u00fajo N, Tsugane S, Hidaka A, et al. \u201cTrue\u201d Helicobacter pylori infection and non-cardia gastric cancer: A pooled analysis within the Stomach Cancer Pooling (StoP) Project. Helicobacter. 2022; 27: e12883.","DOI":"10.1111\/hel.12883"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Ma J, Meng Y, Zhou X, Guo L, Fu W. The Prognostic Significance and Gene Expression Characteristics of Gastric Signet-Ring Cell Carcinoma: A Study Based on the SEER and TCGA Databases. Frontiers in Surgery. 2022; 9: 819018.","DOI":"10.3389\/fsurg.2022.819018"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Xing Y, Hosaka H, Moki F, Tomaru S, Itoi Y, Sato K, et al. Gender Differences in Patients with Gastric Adenocarcinoma. Journal of Clinical Medicine. 2024; 13: 2524.","DOI":"10.3390\/jcm13092524"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Sugano K, Moss SF, Kuipers EJ. Gastric Intestinal Metaplasia: Real Culprit or Innocent Bystander as a Precancerous Condition for Gastric Cancer? Gastroenterology. 2023; 165: 1352\u20131366.e1.","DOI":"10.1053\/j.gastro.2023.08.028"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Burke E, Harkins P, Arumugasamy M. Incidence of Gastric Adenocarcinoma in Those With Gastric Atrophy: A Systematic Review. Cureus. 2024; 16: e71768.","DOI":"10.7759\/cureus.71768"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Chivu RF, Melesteu C, Bobirca A, Dumitrescu DA, Melesteu I, Mustatea P, et al. Advances in Gastric Carcinogenesis Related to Helicobacter Pylori. Chirurgia (Bucharest, Romania: 1990). 2025; 120: 322\u2013344.","DOI":"10.21614\/chirurgia.3147"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"He J, Hu W, Ouyang Q, Zhang S, He L, Chen W, et al. Helicobacter pylori infection induces stem cell-like properties in Correa cascade of gastric cancer. Cancer Letters. 2022; 542: 215764.","DOI":"10.1016\/j.canlet.2022.215764"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Fang Z, Zhang W, Wang H, Zhang C, Li J, Chen W, et al. Helicobacter pylori promotes gastric cancer progression by activating the TGF-\u03b2\/Smad2\/EMT pathway through HKDC1. Cellular and Molecular Life Sciences: CMLS. 2024; 81: 453.","DOI":"10.1007\/s00018-024-05491-x"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Li F, Wang Y, Ping X, Yin JC, Wang F, Zhang X, et al. Molecular evolution of intestinal-type early gastric cancer according to Correa cascade. Journal of Biomedical Research. 2024; 39: 270\u2013285.","DOI":"10.7555\/JBR.38.20240118"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Marashi A, Hasany S, Moghimi S, Kiani R, Mehran Asl S, Dareghlou YA, et al. Targeting gut-microbiota for gastric cancer treatment: a systematic review. Frontiers in Medicine. 2024; 11: 1412709.","DOI":"10.3389\/fmed.2024.1412709"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"He Y, Gao S, Jiang L, Yang J. Changes in gut microbiota after gastric cancer surgery: a prospective longitudinal study. Frontiers in Oncology. 2024; 14: 1533816.","DOI":"10.3389\/fonc.2024.1533816"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Chen Z, Jin D, Hu J, Guan D, Bai Q, Gou Y. Microbiota and gastric cancer: from molecular mechanisms to therapeutic strategies. Frontiers in Cellular and Infection Microbiology. 2025; 15: 1563061.","DOI":"10.3389\/fcimb.2025.1563061"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Albush A, Yassine F, Abbas H, Hanna A, Saba E, Bilen M. The impact of Helicobacter pylori infection and eradication therapies on gut microbiota: a systematic review of microbial dysbiosis and its implications in gastric carcinogenesis. Frontiers in Cellular and Infection Microbiology. 2025; 15: 1592977.","DOI":"10.3389\/fcimb.2025.1592977"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Xie N, Wang Z, Shu Q, Liang X, Wang J, Wu K, et al. Association between Gut Microbiota and Digestive System Cancers: A Bidirectional Two-Sample Mendelian Randomization Study. Nutrients. 2023; 15: 2937.","DOI":"10.3390\/nu15132937"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Chen C, Du Y, Liu Y, Shi Y, Niu Y, Jin G, et al. Characteristics of gastric cancer gut microbiome according to tumor stage and age segmentation. Applied Microbiology and Biotechnology. 2022; 106: 6671\u20136687.","DOI":"10.1007\/s00253-022-12156-x"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Xie J, Xu J, Tian Z, Liang J, Tang H. Extended Insights Into Advancing Multi-Omics and Prognostic Methods for Cancer Prognosis Forecasting. Frontiers in Bioscience (Landmark Edition). 2025; 30: 44091.","DOI":"10.31083\/FBL44091"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Hosseinkhani F, Chevalier C, Marizzoni M, Park R, Bos S, Dunjko AK, et al. Plasma and feces multiomics unveil cognition-associated perturbations of chronic inflammatory pathways of the gut-microbiota-brain axis. Alzheimer\u2019s & Dementia: the Journal of the Alzheimer\u2019s Association. 2025; 21: e70844.","DOI":"10.1002\/alz.70844"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Xie J, Liu M, Deng X, Tang Y, Zheng S, Ou X, et al. Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies. IMeta. 2024; 3: e156.","DOI":"10.1002\/imt2.156"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Liao X, Long J, Wang X, Han K, Tang Z, Chen J, et al. Multi-omics reveals cross-tissue regulatory mechanisms of autism risk loci via gut microbiota-immunity-brain axis. AMB Express. 2025; 15: 161.","DOI":"10.1186\/s13568-025-01969-4"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Li D, Lu Y, Zhao F, Yan L, Yang X, Wei L, et al. Targeted metabolomic profiles of serum amino acids and acylcarnitines related to gastric cancer. PeerJ. 2022; 10: e14115.","DOI":"10.7717\/peerj.14115"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Li B, Shu X, Jiang H, Shi C, Qi L, Zhu L, et al. Plasma metabolome identifies potential biomarkers of gastric precancerous lesions and gastric cancer risk. Metabolomics: Official Journal of the Metabolomic Society. 2023; 19: 73.","DOI":"10.1007\/s11306-023-02037-3"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Nakane K, Yagi K, Yajima S, Nomura S, Sugimoto M, Seto Y. Salivary metabolomic biomarkers for esophageal and gastric cancers by liquid chromatography-mass spectrometry. Cancer Science. 2024; 115: 3089\u20133098.","DOI":"10.1111\/cas.16256"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Bu F, Shen X, Zhan H, Wang D, Min L, Song Y, et al. Efficient Metabolomics Profiling from Plasma Extracellular Vesicles Enables Accurate Diagnosis of Early Gastric Cancer. Journal of the American Chemical Society. 2025; 147: 8672\u20138686.","DOI":"10.1021\/jacs.4c18110"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Wang Y, Han W, Wang N, Han M, Ban M, Dai J, et al. The role of microbiota in the development and treatment of gastric cancer. Frontiers in Oncology. 2023; 13: 1224669.","DOI":"10.3389\/fonc.2023.1224669"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Sharma P, Phatak SM, Warikoo P, Mathur A, Mahant S, Das K, et al. Crosstalk between Helicobacter pylori and gastrointestinal microbiota in various gastroduodenal diseases-A systematic review. 3 Biotech. 2023; 13: 303.","DOI":"10.1007\/s13205-023-03734-5"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Zhu J. New Metabolomic Insights Into Cancer. Cancer Journal (Sudbury, Mass.). 2024; 30: 301\u2013306.","DOI":"10.1097\/PPO.0000000000000740"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Liu C, Liu W, Huang J, Wu Z, Li W, Chen B, et al. Metabolic Reprogramming Shapes the Progression and Therapeutic Landscape of Ovarian Cancer. Cancer Management and Research. 2025; 17: 1707\u20131722.","DOI":"10.2147\/CMAR.S538281"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Idowu S, Polglaze K, Van TTH, Moore RJ, Ramsland PA, Bertrand PP, et al. Gastric Inflammation Impacts Serotonin Secretion in a Mouse Model of Helicobacter pylori Vaccination. International Journal of Molecular Sciences. 2025; 26: 7735.","DOI":"10.3390\/ijms26167735"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Wu D, Cao M, Peng J, Li N, Yi S, Song L, et al. The effect of trimethylamine N-oxide on Helicobacter pylori-induced changes of immunoinflammatory genes expression in gastric epithelial cells. International Immunopharmacology. 2017; 43: 172\u2013178.","DOI":"10.1016\/j.intimp.2016.11.032"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/1\/10.31083\/FBL46553","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:06:02Z","timestamp":1769688362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/1\/10.31083\/FBL46553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6701(26)00061-0"],"URL":"https:\/\/doi.org\/10.31083\/fbl46553","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"article-number":"46553"}}